Latest Regulatory Milestones News

Pure Hydrogen Corporation has secured a 15-year Potential Commercial Area approval and extended its ATP 927 permit for the Windorah Gas Project, marking a critical regulatory milestone ahead of its planned spinout.

Syntara Limited’s lead drug candidate SNT-5505 has secured FDA Fast Track designation, expediting its development for treating myelofibrosis, a rare and serious blood cancer with limited therapies.

Lotus Resources has secured Environmental and Social Impact Assessment approval for its Kayelekera Uranium Project in Malawi, paving the way for uranium production to resume in the third quarter of 2025. The company also completed a key board transition, signaling a new phase in its governance.

Chimeric Therapeutics has secured FDA Fast Track designation for its CHM CDH17 CAR-T therapy targeting gastroenteropancreatic neuroendocrine tumours, accelerating its path toward regulatory approval and patient access.

Recce Pharmaceuticals has completed a A$15.8 million capital raise to fund pivotal Phase 3 clinical trials and progress its FDA application, positioning the company for potential commercial breakthroughs in antibiotic-resistant infections.

EMVision Medical Devices has activated two additional key sites in its pivotal trial for the emu™ bedside brain scanner, advancing its path toward FDA clearance. These new sites join a growing network of leading stroke centres across the US and Australia.

Cardiex Limited has gained Therapeutic Goods Administration approval for its CONNEQT Pulse device, paving the way for commercial expansion in Australia alongside its established US presence.

Manuka Resources’ Taranaki VTM Project has advanced through a critical regulatory checkpoint, with no competing applications or appeals standing in its way, moving closer to expert panel determination.

Equinox Resources has obtained a crucial exploration permit for its Alturas Antimony Project in British Columbia, paving the way for a comprehensive 2025 field program and potential bulk sampling. This milestone advances the company’s strategy amid rising North American demand for critical minerals.

The Arkansas Oil & Gas Commission has approved a 2.5% lithium royalty for brine projects, providing Pantera Lithium with regulatory clarity and a competitive fiscal framework that enhances its Smackover Project’s commercial prospects.

Aston Minerals Limited shares will be suspended from trading following court approval of its acquisition by Torque Metals Limited. This marks a significant step in the consolidation of mining assets in Western Australia.

Sipa Resources has completed key heritage surveys and submitted environmental approvals, setting the stage for maiden drilling at its South Australian gold projects near the 1.6 million ounce Tunkillia deposit.